Caricamento...
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay
Histone deacetylase 3 (HDAC3) is a potential target for the treatment of human diseases such as cancers, diabetes, chronic inflammation and neurodegenerative diseases. Previously, we proposed a virtual screening (VS) pipeline named “Hypo1_FRED_SAHA-3” for the discovery of HDAC3 inhibitors (HDAC3Is)...
Salvato in:
| Pubblicato in: | J Enzyme Inhib Med Chem |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5978667/ https://ncbi.nlm.nih.gov/pubmed/29464997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2018.1437156 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|